0.024337 0.000000 0.000000 0.000000 0.024337 0.000000 0.000000 0.000000 0.009441 0.00000 0.00000 0.00000 Murray, A.J. Head, J.G. Barker, J.J. Brady, R.L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 8 90.00 90.00 90.00 41.090 41.090 105.920 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Nat.Struct.Biol. NSBIEW 2024 1072-8368 5 778 782 10.1038/1816 9731771 Engineering an intertwined form of CD2 for stability and assembly. 1998 10.2210/pdb1a6p/pdb pdb_00001a6p 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 287 1 MIRRORS IMAGE PLATE 1997-08 MARRESEARCH MIRRORS M x-ray 1 1.488 1.0 PX7.2 SRS 1.488 SYNCHROTRON SRS BEAMLINE PX7.2 10538.900 T-CELL SURFACE ANTIGEN CD2 DOMAIN 1 DEL(M46, K47) 2 man polymer 18.015 water 81 nat water no no GTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKPFLKSGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNG TRILDKALDLRILE GTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKPFLKSGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNG TRILDKALDLRILE A,B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Norway rat Rattus Escherichia sample T-LYMPHOCYTES 10116 Rattus norvegicus CYTOPLASM 562 Escherichia coli MC1061 PLASMID PGEX-2T 1 2.08 31.8 4.6 20% PEG 4000, 5% GLYCEROL, 0.1M NACO, PH 4.6 database_2 pdbx_database_status pdbx_initial_refinement_model struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Other Refinement description 1 0 1998-06-17 1 1 2008-03-24 1 2 2011-07-13 1 3 2023-08-02 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_ref_seq_dif.details Y BNL 1998-02-26 REL REL HOH water 1HNG PDB ENTRY 1HNG PDB experimental model HOH 3 2 HOH HOH 100 A HOH 4 2 HOH HOH 101 A HOH 5 2 HOH HOH 102 A HOH 8 2 HOH HOH 103 A HOH 11 2 HOH HOH 104 A HOH 12 2 HOH HOH 105 A HOH 15 2 HOH HOH 106 A HOH 16 2 HOH HOH 107 A HOH 18 2 HOH HOH 108 A HOH 19 2 HOH HOH 109 A HOH 21 2 HOH HOH 110 A HOH 22 2 HOH HOH 111 A HOH 26 2 HOH HOH 112 A HOH 34 2 HOH HOH 113 A HOH 35 2 HOH HOH 114 A HOH 36 2 HOH HOH 115 A HOH 38 2 HOH HOH 116 A HOH 49 2 HOH HOH 117 A HOH 57 2 HOH HOH 118 A HOH 59 2 HOH HOH 119 A HOH 61 2 HOH HOH 120 A HOH 62 2 HOH HOH 121 A HOH 71 2 HOH HOH 122 A HOH 72 2 HOH HOH 123 A HOH 82 2 HOH HOH 124 A HOH 89 2 HOH HOH 125 A HOH 92 2 HOH HOH 126 A HOH 96 2 HOH HOH 127 A HOH 106 2 HOH HOH 128 A HOH 202 2 HOH HOH 129 A HOH 203 2 HOH HOH 130 A HOH 206 2 HOH HOH 131 A HOH 207 2 HOH HOH 132 A HOH 210 2 HOH HOH 133 A HOH 211 2 HOH HOH 134 A HOH 214 2 HOH HOH 135 A HOH 217 2 HOH HOH 136 A HOH 218 2 HOH HOH 137 A HOH 219 2 HOH HOH 138 A HOH 220 2 HOH HOH 139 A HOH 221 2 HOH HOH 140 A HOH 222 2 HOH HOH 141 A HOH 223 2 HOH HOH 142 A HOH 224 2 HOH HOH 143 A HOH 225 2 HOH HOH 144 A HOH 226 2 HOH HOH 145 A HOH 227 2 HOH HOH 146 A HOH 228 2 HOH HOH 147 A HOH 232 2 HOH HOH 148 A HOH 236 2 HOH HOH 149 A HOH 237 2 HOH HOH 150 A HOH 238 2 HOH HOH 151 A HOH 246 2 HOH HOH 152 A HOH 248 2 HOH HOH 153 A HOH 1 2 HOH HOH 100 B HOH 2 2 HOH HOH 101 B HOH 7 2 HOH HOH 102 B HOH 9 2 HOH HOH 103 B HOH 10 2 HOH HOH 104 B HOH 14 2 HOH HOH 105 B HOH 27 2 HOH HOH 106 B HOH 29 2 HOH HOH 107 B HOH 32 2 HOH HOH 108 B HOH 47 2 HOH HOH 109 B HOH 52 2 HOH HOH 110 B HOH 55 2 HOH HOH 111 B HOH 58 2 HOH HOH 112 B HOH 63 2 HOH HOH 113 B HOH 77 2 HOH HOH 114 B HOH 112 2 HOH HOH 115 B HOH 113 2 HOH HOH 116 B HOH 120 2 HOH HOH 117 B HOH 216 2 HOH HOH 118 B HOH 229 2 HOH HOH 119 B HOH 233 2 HOH HOH 120 B HOH 235 2 HOH HOH 121 B HOH 239 2 HOH HOH 122 B HOH 240 2 HOH HOH 123 B HOH 241 2 HOH HOH 124 B HOH 242 2 HOH HOH 125 B HOH 244 2 HOH HOH 126 B GLY 4 n 1 GLY 4 A THR 5 n 2 THR 5 A VAL 6 n 3 VAL 6 A TRP 7 n 4 TRP 7 A GLY 8 n 5 GLY 8 A ALA 9 n 6 ALA 9 A LEU 10 n 7 LEU 10 A GLY 11 n 8 GLY 11 A HIS 12 n 9 HIS 12 A GLY 13 n 10 GLY 13 A ILE 14 n 11 ILE 14 A ASN 15 n 12 ASN 15 A LEU 16 n 13 LEU 16 A ASN 17 n 14 ASN 17 A ILE 18 n 15 ILE 18 A PRO 19 n 16 PRO 19 A ASN 20 n 17 ASN 20 A PHE 21 n 18 PHE 21 A GLN 22 n 19 GLN 22 A MET 23 n 20 MET 23 A THR 24 n 21 THR 24 A ASP 25 n 22 ASP 25 A ASP 26 n 23 ASP 26 A ILE 27 n 24 ILE 27 A ASP 28 n 25 ASP 28 A GLU 29 n 26 GLU 29 A VAL 30 n 27 VAL 30 A ARG 31 n 28 ARG 31 A TRP 32 n 29 TRP 32 A GLU 33 n 30 GLU 33 A ARG 34 n 31 ARG 34 A GLY 35 n 32 GLY 35 A SER 36 n 33 SER 36 A THR 37 n 34 THR 37 A LEU 38 n 35 LEU 38 A VAL 39 n 36 VAL 39 A ALA 40 n 37 ALA 40 A GLU 41 n 38 GLU 41 A PHE 42 n 39 PHE 42 A LYS 43 n 40 LYS 43 A ARG 44 n 41 ARG 44 A LYS 45 n 42 LYS 45 A PRO 48 n 43 PRO 48 A PHE 49 n 44 PHE 49 A LEU 50 n 45 LEU 50 A LYS 51 n 46 LYS 51 A SER 52 n 47 SER 52 A GLY 53 n 48 GLY 53 A ALA 54 n 49 ALA 54 A PHE 55 n 50 PHE 55 A GLU 56 n 51 GLU 56 A ILE 57 n 52 ILE 57 A LEU 58 n 53 LEU 58 A ALA 59 n 54 ALA 59 A ASN 60 n 55 ASN 60 A GLY 61 n 56 GLY 61 A ASP 62 n 57 ASP 62 A LEU 63 n 58 LEU 63 A LYS 64 n 59 LYS 64 A ILE 65 n 60 ILE 65 A LYS 66 n 61 LYS 66 A ASN 67 n 62 ASN 67 A LEU 68 n 63 LEU 68 A THR 69 n 64 THR 69 A ARG 70 n 65 ARG 70 A ASP 71 n 66 ASP 71 A ASP 72 n 67 ASP 72 A SER 73 n 68 SER 73 A GLY 74 n 69 GLY 74 A THR 75 n 70 THR 75 A TYR 76 n 71 TYR 76 A ASN 77 n 72 ASN 77 A VAL 78 n 73 VAL 78 A THR 79 n 74 THR 79 A VAL 80 n 75 VAL 80 A TYR 81 n 76 TYR 81 A SER 82 n 77 SER 82 A THR 83 n 78 THR 83 A ASN 84 n 79 ASN 84 A GLY 85 n 80 GLY 85 A THR 86 n 81 THR 86 A ARG 87 n 82 ARG 87 A ILE 88 n 83 ILE 88 A LEU 89 n 84 LEU 89 A ASP 90 n 85 ASP 90 A LYS 91 n 86 LYS 91 A ALA 92 n 87 ALA 92 A LEU 93 n 88 LEU 93 A ASP 94 n 89 ASP 94 A LEU 95 n 90 LEU 95 A ARG 96 n 91 ARG 96 A ILE 97 n 92 ILE 97 A LEU 98 n 93 LEU 98 A GLU 99 n 94 GLU 99 A GLY 4 n 1 GLY 4 B THR 5 n 2 THR 5 B VAL 6 n 3 VAL 6 B TRP 7 n 4 TRP 7 B GLY 8 n 5 GLY 8 B ALA 9 n 6 ALA 9 B LEU 10 n 7 LEU 10 B GLY 11 n 8 GLY 11 B HIS 12 n 9 HIS 12 B GLY 13 n 10 GLY 13 B ILE 14 n 11 ILE 14 B ASN 15 n 12 ASN 15 B LEU 16 n 13 LEU 16 B ASN 17 n 14 ASN 17 B ILE 18 n 15 ILE 18 B PRO 19 n 16 PRO 19 B ASN 20 n 17 ASN 20 B PHE 21 n 18 PHE 21 B GLN 22 n 19 GLN 22 B MET 23 n 20 MET 23 B THR 24 n 21 THR 24 B ASP 25 n 22 ASP 25 B ASP 26 n 23 ASP 26 B ILE 27 n 24 ILE 27 B ASP 28 n 25 ASP 28 B GLU 29 n 26 GLU 29 B VAL 30 n 27 VAL 30 B ARG 31 n 28 ARG 31 B TRP 32 n 29 TRP 32 B GLU 33 n 30 GLU 33 B ARG 34 n 31 ARG 34 B GLY 35 n 32 GLY 35 B SER 36 n 33 SER 36 B THR 37 n 34 THR 37 B LEU 38 n 35 LEU 38 B VAL 39 n 36 VAL 39 B ALA 40 n 37 ALA 40 B GLU 41 n 38 GLU 41 B PHE 42 n 39 PHE 42 B LYS 43 n 40 LYS 43 B ARG 44 n 41 ARG 44 B LYS 45 n 42 LYS 45 B PRO 48 n 43 PRO 48 B PHE 49 n 44 PHE 49 B LEU 50 n 45 LEU 50 B LYS 51 n 46 LYS 51 B SER 52 n 47 SER 52 B GLY 53 n 48 GLY 53 B ALA 54 n 49 ALA 54 B PHE 55 n 50 PHE 55 B GLU 56 n 51 GLU 56 B ILE 57 n 52 ILE 57 B LEU 58 n 53 LEU 58 B ALA 59 n 54 ALA 59 B ASN 60 n 55 ASN 60 B GLY 61 n 56 GLY 61 B ASP 62 n 57 ASP 62 B LEU 63 n 58 LEU 63 B LYS 64 n 59 LYS 64 B ILE 65 n 60 ILE 65 B LYS 66 n 61 LYS 66 B ASN 67 n 62 ASN 67 B LEU 68 n 63 LEU 68 B THR 69 n 64 THR 69 B ARG 70 n 65 ARG 70 B ASP 71 n 66 ASP 71 B ASP 72 n 67 ASP 72 B SER 73 n 68 SER 73 B GLY 74 n 69 GLY 74 B THR 75 n 70 THR 75 B TYR 76 n 71 TYR 76 B ASN 77 n 72 ASN 77 B VAL 78 n 73 VAL 78 B THR 79 n 74 THR 79 B VAL 80 n 75 VAL 80 B TYR 81 n 76 TYR 81 B SER 82 n 77 SER 82 B THR 83 n 78 THR 83 B ASN 84 n 79 ASN 84 B GLY 85 n 80 GLY 85 B THR 86 n 81 THR 86 B ARG 87 n 82 ARG 87 B ILE 88 n 83 ILE 88 B LEU 89 n 84 LEU 89 B ASP 90 n 85 ASP 90 B LYS 91 n 86 LYS 91 B ALA 92 n 87 ALA 92 B LEU 93 n 88 LEU 93 B ASP 94 n 89 ASP 94 B LEU 95 n 90 LEU 95 B ARG 96 n 91 ARG 96 B ILE 97 n 92 ILE 97 B LEU 98 n 93 LEU 98 B GLU 99 n 94 GLU 99 B author_and_software_defined_assembly PISA 2 dimeric 7390 -38 10560 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O VAL 6 A O VAL 3 B N ASP 94 B N ASP 89 B O ILE 88 B O ILE 83 B N VAL 80 B N VAL 75 B O ASN 77 B O ASN 72 A N GLU 33 A N GLU 30 A O VAL 30 A O VAL 27 A N PHE 42 A N PHE 39 A O ILE 14 A O ILE 11 B N ILE 65 B N ILE 60 B O LYS 64 B O LYS 59 B N GLU 56 B N GLU 51 A O GLU 56 A O GLU 51 A N LYS 64 A N LYS 59 A O LEU 63 A O LEU 58 B N LEU 16 B N LEU 13 B O VAL 6 B O VAL 3 A N ASP 94 A N ASP 89 A O ILE 88 A O ILE 83 A N VAL 80 A N VAL 75 A O ASN 77 A O ASN 72 B N GLU 33 B N GLU 30 B O VAL 30 B O VAL 27 B N PHE 42 B N PHE 39 1 A A CD OE2 GLU GLU 99 99 0.074 0.011 1.252 1.326 N 1 B B CD OE2 GLU GLU 99 99 0.071 0.011 1.252 1.323 N 1 A ASN 20 39.43 72.64 1 A ASP 26 -92.47 30.96 1 B ASN 20 37.43 80.88 PARHCSDX.PRO TOPHCSDX.PRO 32.46 RESIDUES 20 - 29 IN BOTH CHAINS COMPRISE A FLEXIBLE LOOP REGION; HENCE THE B FACTORS ARE HIGH WITH POOR PACKING, AND SOME NON H-BOND DONORS IN THE AREA. 0.2960000 0.2186000 0.2186000 2.08 15. 10520 10589 10. 99.1 RANDOM 2.08 10. 1 THROUGHOUT 0. MOLECULAR REPLACEMENT PDB ENTRY 1HNG 2.08 15. 88 1572 0 0 1484 0.006 1.291 0.3793000 0.027 0.3005000 2.17 116 1070 8 10.5 99.1 24.34 2.0 15. 1A6P 10589 0. 0.0590000 0.0590000 1 16.1 2.89 99.1 0.2950000 2.08 2.15 2.57 0.2950000 99. model building X-PLOR 3.851 refinement X-PLOR 3.851 data reduction DENZO data scaling SCALEPACK phasing X-PLOR 3.851 ENGINEERING OF A MISFOLDED FORM OF CD2 1 N N 1 N N 2 N N 2 N N A ARG 70 A ARG 65 HELX_P A ASP 72 A ASP 67 5 1 3 B ARG 70 B ARG 65 HELX_P B ASP 72 B ASP 67 5 2 3 CELL ADHESION DOMAIN SWAPPING, HINGE LOOP, OLIGOMER EVOLUTION, T LYMPHOCYTE ADHESION GLYCOPROTEIN, CELL ADHESION CD2_RAT UNP 1 1 P08921 MRCKFLGSFFLLFSLSSKGADCRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGAFEIL ANGDLKIKNLTRDDSGTYNVTVYSTNGTRILDKALDLRILEMVSKPMIYWECSNATLTCEVLEGTDVELKLYQGKEHLRS LRQKTMSYQWTNLRAPFKCKAVNRVSQESEMEVVNCPEKGLPLYLIVGVSAGGLLLVFFGALFIFCICKRKKRNRRRKGE ELEIKASRMSTVERGPKPHSTQASAPASQNPVASQAPPPPGHHLQTPGHRPLPPSHRNREHQPKKRPPPSGTQVHQQKGP PLPRPRVQPKPPCGSGDVSLPPPN 26 121 1A6P 4 99 P08921 A 1 1 94 26 121 1A6P 4 99 P08921 B 1 1 94 1 MET deletion 1A6P A P08921 UNP 68 1 LYS deletion 1A6P A P08921 UNP 69 2 MET deletion 1A6P B P08921 UNP 68 2 LYS deletion 1A6P B P08921 UNP 69 5 3 3 5 parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel parallel anti-parallel anti-parallel anti-parallel A THR 5 A THR 2 A ALA 9 A ALA 6 B ARG 87 B ARG 82 B LEU 98 B LEU 93 B GLY 74 B GLY 69 B SER 82 B SER 77 A ILE 27 A ILE 24 A ARG 34 A ARG 31 A THR 37 A THR 34 A LYS 43 A LYS 40 A ILE 14 A ILE 11 A LEU 16 A LEU 13 B LEU 63 B LEU 58 B ILE 65 B ILE 60 B PHE 55 B PHE 50 B ILE 57 B ILE 52 A PHE 55 A PHE 50 A ILE 57 A ILE 52 A LEU 63 A LEU 58 A ILE 65 A ILE 60 B ILE 14 B ILE 11 B LEU 16 B LEU 13 B THR 5 B THR 2 B ALA 9 B ALA 6 A ARG 87 A ARG 82 A LEU 98 A LEU 93 A GLY 74 A GLY 69 A SER 82 A SER 77 B ILE 27 B ILE 24 B ARG 34 B ARG 31 B THR 37 B THR 34 B LYS 43 B LYS 40 78 P 43